BCT introduces Metastatic Trial Talk plus the re-designed Metastatic Trial Search

June 27, 2018

Metastatic Breast Cancer clinical trial matching service upgraded to better serve the MBC community

San Francisco, CA (June 27, 2018) – BreastCancerTrials.org (BCT) has launched an upgraded version of Metastatic Trial Search (MTS) with improved search and filtering options. Now patients have even more customizable options for finding clinical trials.

BCT also launched Metastatic Trial Talk (MTT), a new companion application that provides patients with carefully selected news and features about metastatic breast cancer research.

MTS and MTT bring access to and awareness of clinical trials in one convenient place. Check them out.

About BreastCancerTrials.org (BCT)

BreastCancerTrials.org is a non-profit service that encourages individuals affected by breast cancer to consider clinical trials as a routine option for care. To make this possible, the web-based portal helps individuals who are interested in breast cancer research find studies that are right for them; lists U.S.-based trials on ClinicalTrials.gov that are currently looking for volunteers; provides accurate information about why clinical trials are important and how they are structured; and helps care providers and patient navigators find trials for patients. BCT was developed at the University of California, San Francisco and operates as a service of Quantum Leap Healthcare Collaborative, a non-profit foundation, established in 2005, as a collaboration between medical researchers at University of California at San Francisco, and Silicon Valley entrepreneurs. QuantumLeap’s mission is to accelerate the transfer of high-impact research in clinical processes and systems technology into widespread adoption so that patients and physicians can benefit from the research as soon as practicable.

For more information, email k.zeitzer@quantumleaphealth.org